FACT SHEET: Goals of the COVID-19 Global Summit


We invite all participants of the COVID-19 Global Summit to join us in aligning with the global goals and taking the associated necessary actions to end the COVID-19 pandemic and build back better. These global goals and the associated actions of governments, international institutions and the private sector are drawn from the goals defined by the Multilateral Leaders’ Working Group on COVID-19, the COVID-19 Tool Access Accelerator (ACT) , the G20, the G7 and members of several expert committees.

These objectives and associated actions are ambitious – but they are what we need to get us on track to end this pandemic and with it, the risk it poses to our countries, communities, health and livelihoods. We must act now to immunize the world, save lives and build back better. Only by working together in pursuit of a common vision can we defeat the COVID-19 pandemic and help prepare the world for future pandemics.

We also invite all participants to join us in monitoring our collective progress. By aggregating information about what each of us is doing, we can measure our progress and take action to stay on track.


  • Vaccinate the world: Support WHO’s goal of at least 70% of the population fully immunized with quality, safe and effective vaccines in every country and income group by UNGA 2022.
  • Deliver emergency doses: Endorse the G20 goal of “in accordance with the World Health Organization (WHO), we support the goal of vaccinating at least 40% by the end of 2021 of the world’s population”.
  • Making medium and long term doses: Additional doses and adequate supplies are available for all countries in 2022. As scientific evidence grows, make sufficient funding available for the production of additional doses for future booster needs in LICs / LMICs.

Requests from governments and international institutions with relevant capacities: fall 2021

  • Close the financing and supply gap for Low Income Countries (LICs) / Low Middle Income Countries (LMICs) to achieve 70 percent coverage by providing funds, purchasing or donating an additional 1 billion doses of quality, safe and effective COVID-19 vaccines, including through COVAX to support equitable distribution globally.
  • Accelerate vaccination in LICs / PRFIs in 2021 by accelerating the delivery of approximately 2.0 billion already committed doses of quality, safe and effective COVID-19 vaccines, including converting existing dose-sharing pledges into short-term deliveries, swapping delivery dates to ensure faster delivery of doses to LMICs and eliminating cross-border bottlenecks in the supply of essential vaccines and inputs.
  • Get shots in the arms making available at least $ 3 billion in 2021 and $ 7 billion in 2022 in funding for LICs / PRFRs for the preparation and effective deployment of vaccines, including supporting the health workforce needed to distribute vaccines, combating hesitation, meeting legal and contractual requirements, and purchasing ancillary supplies.
  • Make the doses available in the medium and long term supporting sufficient global and regional production, as well as funding possible booster needs and future vaccine production; expansion of mRNA, viral vector and protein subunit vaccine manufacturing (if permitted) and technology transfer; and purchase up to 3 billion additional doses of quality, safe and effective vaccines for LICs / PRFIs if boosters are recommended by WHO.
  • Improve accountability and coordination establishing a robust global dashboard for vaccines, consumables and ancillary supplies in 2021, taking into account existing efforts to achieve this goal.

Proposed private sector commitments: fall 2021

  • Launch COVID-19 Corps for vaccine preparation and delivery.
  • Improve transparency on the volume of actual and planned manufacture of vaccines; Provide data on production projections and delivery sequencing for the vaccine dashboard, in order to prioritize delivery for LICs / PRFIs.
  • Develop the global and regional manufacture of vaccines against the mRNA, the viral vector and / or the COVID-19 protein subunit, with a development and financing plan.


  • Solve the oxygen crisis making oxygen readily available to inpatient healthcare facilities in all countries in the short term and no later than 2022.
  • Eliminate the test gap by achieving screening rates of one per 1,000 people per day by the end of 2021, in all countries.
  • Improve timely access for all countries to quality, safe and effective authorized treatments by making them available to all LICs / PRFIs in 2021, and new effective non-intravenous treatments are available in 2022.
  • Build a state-of-the-art PPE manufacturing capacity and strengthen the coordination of existing stocks to improve access to PPE for all health workers in LICs / PRFRs in 2021, with surge capacity available for each region in 2022.
  • Improve detection, monitoring and mitigation of new COVID-19 variants improving genomic sequencing and data sharing efforts globally in 2021 and 2022.

Requests from governments and international institutions with relevant capacities: fall 2021

  • Provide $ 2 billion in coordinated support to oxygenated ecosystems, including increasing the availability of bulk liquid oxygen in LICs / PRFIs by 2022.
  • Fund at least 1 billion quality, safe and effective kits / tests by 2022 for LICs / PRFIs.
  • Donate and provide sufficient ongoing $ 1 billion of approved COVID-19 therapies for LICs / LMICs by 2022, and $ 2 billion in 2022, and establish a mechanism for equitable procurement and distribution of commodities therapeutic.
  • Support the establishment of an advanced PPE manufacturing capacity and strengthen distribution in each region in 2022.
  • Endorse the Carbis Bay G7 / S7 statement to enhance global variant tracking and analysis capabilities by providing resources to expand global capabilities and support the concept of a global pandemic radar.

Proposed private sector commitments: fall 2021

  • In collaboration with countries and international institutions, design and fund a global $ 2 billion strategy to support oxygen ecosystems, including the provision of bulk liquid oxygen and other supports to hospitals in all countries by the end of 2022.
  • Improve test production, by making test kits available in low-income and low-income countries for no more than $ 1 per antigen kit.
  • Develop production and make authorized therapies available for 12 million severe and critical patients.
  • Fund advanced development, including clinical trials and voluntary technology transfer

for next-generation COVID-19 therapies (ideally oral) for low-resource settings.

  • Commit to bringing together global stakeholders, including the private sector and civil society, dedicated to building and coordinating transformative capacities for global tracking of variants.


  • Create sustainable financing for health security by creating and financing a Global Health Security Financial Intermediation Fund (FIF) in 2021.
  • Catalyze political leadership and attention for biological crises, in particular by creating a leading-level entity, such as the Global Health Threats Council (GHTC) in 2021.
  • Support the G20 Presidency’s Call to Action for a Global Ministerial Council on Health and Finance.

Requests from governments and international institutions with relevant capacities: fall 2021

  • At least 30 countries and at least 10 organizations sign to establish a global health security IFF, with a shared vision on scope, level of seed funding (e.g. $ 10 billion) and host (e.g. Bank world).
  • Announce commitments in 2021 to initiate the IFF for urgent preparedness needs, with specific proposals for medium-term sustainable funding that include sources outside of official development assistance.
  • Promises of advanced manufacturing and resilient supply chains for PPE, testing, therapeutics and vaccines in all regions.
  • Work towards the creation of a leader-level entity, such as the GHTC, in 2021, including the identification of a chair and a co-chair.

Proposed private sector commitments: fall 2021

  • Individuals or organizations commit to contribute to the IFF and launch a “challenge” that rallies the non-governmental sector to sustainably support global health security capacity.
  • Individuals or organizations convene individuals and philanthropic organizations to create their own investment fund that feeds the FIF.
  • Individuals or organizations are calling on governments to establish a GHTC at the political level which should include seats for civil society, the private sector and / or experts.



Leave A Reply